ORBON CORP has a total of 12 patent applications. Its first patent ever was published in 1989. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and medical technology are IMPAX PHARMACEUTICALS INC, COMBOCAP INC and ASAMEDIC AS.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | United States | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Australia | 2 | |
#5 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Medical purpose containers | |
#3 | Implantable devices |
# | Name | Total Patents |
---|---|---|
#1 | Chiou George C Y | 8 |
#2 | Richeal Rodger J | 6 |
#3 | Hemmes Paul R | 3 |
#4 | Senatori Mark D | 3 |
#5 | Mckinnon Ray | 3 |
#6 | Chen Jeffrey Y | 3 |
#7 | Loong-Lim Wai | 3 |
#8 | Richeal R J | 1 |
#9 | Chiou G C Y | 1 |
#10 | Hemmes P R | 1 |
Publication | Filing date | Title |
---|---|---|
WO0130337A2 | Ophthalmic formulation of dopamine antagonists | |
AU4726299A | Drug dispenser | |
WO9924019A1 | Stabilized, dry pharmaceutical compositions for drug delivery and methods of preparing same | |
US5278142A | Systemic delivery of polypeptides through the eye | |
US5182258A | Systemic delivery of polypeptides through the eye |